<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39347336</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Asymptomatic COVID-19 Infection-Induced Rhabdomyolysis in the Backdrop of Statin-Cyclosporine Drug Interaction.</ArticleTitle><Pagination><StartPage>e68127</StartPage><MedlinePgn>e68127</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e68127</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.68127</ELocationID><Abstract><AbstractText>Rhabdomyolysis involves skeletal muscle breakdown leading to high serum creatine kinase (CK) levels and myoglobinuria. Here, we report the case of a middle-aged man who developed rhabdomyolysis, resulting in acute kidney injury (AKI) over pre-existing chronic kidney disease (stage 3a) secondary to focal segmental glomerulosclerosis (primary FSGS), during an asymptomatic COVID-19 infection. The patient had been on treatment with cyclosporine and statin, among other drugs, for his comorbidities. He had initially presented to the hospital after a fall due to difficulty walking in the setting of increasing edema. Lab workup revealed elevated CK and AKI. Urinalysis showed "large" blood on a dipstick with only two RBCs per high-power field on microscopy, suggesting myoglobinuria. A standard respiratory pathogen polymerase chain reaction panel revealed positive SARS-CoV-2. The chest X-ray and oxygenation were normal, and he had no respiratory symptoms. He was treated with intravenous fluids and albumin, with a steady improvement in renal function. Our case underlines that rhabdomyolysis can occur in asymptomatic COVID-19 infection. Therefore, it may be worth monitoring CK levels in COVID-19-positive patients with risk factors for rhabdomyolysis, such as the concurrent usage of statins and cyclosporine, even if they are otherwise asymptomatic.</AbstractText><CopyrightInformation>Copyright © 2024, Nayak M et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nayak M</LastName><ForeName>Vivek</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Internal Medicine, Kasturba Medical College, Manipal, Manipal, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bipasha</LastName><ForeName>Fnu</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Internal Medicine, Government Medical College and Hospital, Chandigarh, IND.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine, MedStar Union Memorial Hospital, Baltimore, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neelakantappa</LastName><ForeName>Kotresha</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Nephrology, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">chronic kidney disease</Keyword><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">creatine kinase</Keyword><Keyword MajorTopicYN="N">cyclosporine</Keyword><Keyword MajorTopicYN="N">myoglobin</Keyword><Keyword MajorTopicYN="N">rhabdomyolysis</Keyword><Keyword MajorTopicYN="N">statin</Keyword></KeywordList><CoiStatement>Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>10</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39347336</ArticleId><ArticleId IdType="pmc">PMC11438487</ArticleId><ArticleId IdType="doi">10.7759/cureus.68127</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19-associated rhabdomyolysis: a scoping review. Preger A, Wei R, Berg B, Golomb BA. http://www.ijidonline.com/article/S1201971223007130/fulltext. Int J Infect Dis. 2023;136:115–126.</Citation><ArticleIdList><ArticleId IdType="pubmed">37730012</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanley M, Chippa V, Aeddula NR, Rodriguez BSQ, Adigun R. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2024. Rhabdomyolysis.</Citation><ArticleIdList><ArticleId IdType="pubmed">28846335</ArticleId></ArticleIdList></Reference><Reference><Citation>The syndrome of rhabdomyolysis: pathophysiology and diagnosis. Giannoglou GD, Chatzizisis YS, Misirli G. Eur J Intern Med. 2007;18:90–100.</Citation><ArticleIdList><ArticleId IdType="pubmed">17338959</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug-related myopathies of which the clinician should be aware. Valiyil R, Christopher-Stine L. Curr Rheumatol Rep. 2010;12:213–220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3092639</ArticleId><ArticleId IdType="pubmed">20425521</ArticleId></ArticleIdList></Reference><Reference><Citation>rhabdomyolysis: a review of the literature. Khan FY. https://www.njmonline.nl/getpdf.php?id=842. Neth J Med. 2009;67:272–283.</Citation><ArticleIdList><ArticleId IdType="pubmed">19841484</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhabdomyolysis after COVID-19 infection: a case report and review of the literature. Bawor M, Sairam S, Rozewicz R, Viegas S, Comninos AN, Abbara A. Viruses. 2022;14:2255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9611306</ArticleId><ArticleId IdType="pubmed">36298810</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhabdomyolysis and acute kidney injury as leading COVID-19 presentation in an adolescent. Tram N, Chiodini B, Montesinos I, et al.  https://journals.lww.com/pidj/fulltext/2020/10000/rhabdomyolysis_and_acute_kidney_injury_as_leading.23.aspx Pediatr Infect Dis J. 2020;39:314–315.</Citation><ArticleIdList><ArticleId IdType="pubmed">32932331</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhabdomyolysis as the initial presentation of SARS-CoV-2 in an adolescent. Gilpin S, Byers M, Byrd A, Cull J, Peterson D, Thomas B, Jacobson P. Pediatrics. 2021;147:2020019273.</Citation><ArticleIdList><ArticleId IdType="pubmed">33037123</ArticleId></ArticleIdList></Reference><Reference><Citation>Anwar MY, Gupta V. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2024. Myoglobinuria.</Citation><ArticleIdList><ArticleId IdType="pubmed">32491311</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhabdomyolysis: review of the literature. Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJA, de Visser M. http://www.nmd-journal.com/article/S096089661400131X/fulltext. Neuromuscul Disord. 2014;24:651–659.</Citation><ArticleIdList><ArticleId IdType="pubmed">24946698</ArticleId></ArticleIdList></Reference><Reference><Citation>Molecular mechanisms of rhabdomyolysis-induced kidney injury: from bench to bedside. Hebert JF, Burfeind KG, Malinoski D, Hutchens MP. Kidney Int Rep. 2023;8:17–29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9831947</ArticleId><ArticleId IdType="pubmed">36644345</ArticleId></ArticleIdList></Reference><Reference><Citation>Statin induced myopathy among patients attending the National Center for Diabetes, Endocrinology, and Genetics. Abed W, Abujbara M, Batieha A, Ajlouni K. Ann Med Surg (Lond) 2022;74:103304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8818528</ArticleId><ArticleId IdType="pubmed">35145672</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine. Maltz HC, Balog DL, Cheigh JS. Ann Pharmacother. 1999;33:1176–1179.</Citation><ArticleIdList><ArticleId IdType="pubmed">10573315</ArticleId></ArticleIdList></Reference><Reference><Citation>Suspected levetiracetam-induced rhabdomyolysis: a case report and literature review. Moinuddin IA. Am J Case Rep. 2020;21:926064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7603803</ArticleId><ArticleId IdType="pubmed">33112844</ArticleId></ArticleIdList></Reference><Reference><Citation>Levetiracetam-induced rhabdomyolysis: a case report and literature review. Kubota K, Yamamoto T, Kawamoto M, Kawamoto N, Fukao T. https://neurology-asia.org/articles/neuroasia-2017-22(3)-275.pdf Neurol Asia. 2017;22:275–278.</Citation></Reference><Reference><Citation>Rhabdomyolysis in a patient with severe hypothyroidism. Salehi N, Agoston E, Munir I, Thompson GJ. Am J Case Rep. 2017;18:912–918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5574522</ArticleId><ArticleId IdType="pubmed">28827517</ArticleId></ArticleIdList></Reference><Reference><Citation>Antipsychotic use and the risk of rhabdomyolysis. Packard K, Price P, Hanson A. J Pharm Pract. 2014;27:501–512.</Citation><ArticleIdList><ArticleId IdType="pubmed">24429293</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhabdomyolysis-induced acute renal injury in a schizophrenic patient. Tiglis M, Hurmuzache T, Bologa C, Neagu TP, Mirea L, Grintescu IM. J Crit Care Med (Targu Mures) 2020;6:249–252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7648442</ArticleId><ArticleId IdType="pubmed">33200097</ArticleId></ArticleIdList></Reference><Reference><Citation>Aripiprazole-associated rhabdomyolysis in a 17-year-old male. Kutlu A, Songür ÇY, Apa H. Arch Iran Med. 2023;26:50–53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10685809</ArticleId><ArticleId IdType="pubmed">37543922</ArticleId></ArticleIdList></Reference><Reference><Citation>Risperidone-associated rhabdomyolysis without neuroleptic malignant syndrome: a case report. Look ML, Boo YL, Chin PW, Hoo FK. J Clin Psychopharmacol. 2017;37:105–106.</Citation><ArticleIdList><ArticleId IdType="pubmed">27861195</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>